HALOPERIDOL DECANOATE

Clinical Indication

Schizophrenia

Comments

Full SCA     Request form

Date of classification

June 2012

Orange

Higher risk medicines requiring significant regular monitoring which would be initiated by or at the recommendation of a specialist service which may include mental health services, secondary care, tertiary care, community providers, private providers and GPs with a specialist interest.